Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases
$136,871N01FY2022AINIH
Duke University, Durham NC
Investigators
Abstract
The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.
View original record on NIH RePORTER →